Literature DB >> 11972986

Adverse effects of immunotherapeutics involving the immune system.

T Vial1, G Choquet-Kastylevsky, J Descotes.   

Abstract

Immunotherapeutics are pharmaceutical products intended to modify immune functions either directly or indirectly by influencing physiological systems that affect immunological functions. They include conventional immunosuppressants, monoclonal antibodies, recombinant cytokines, gene therapy products or therapeutic vaccines. A variety of adverse effects involving the immune system have been described in laboratory animals as well as in the clinic. Some of these adverse effects can be predicted, at least to some extent, from the immunopharmacological profile of these drugs, but a number of unpredicted adverse effects have been described. Immunosuppression, allergy, autoimmunity, immunoactivation are the major adverse consequences to be expected as illustrated by this overview of the leading immunotherapeutics already used in the clinic. These untoward and potentially severe consequences support the need for a careful preclinical and clinical evaluation of the immunotoxicity of these products.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11972986     DOI: 10.1016/s0300-483x(02)00051-3

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  8 in total

Review 1.  Environmental risk factors of systemic sclerosis.

Authors:  Isabelle Marie; Jean-François Gehanno
Journal:  Semin Immunopathol       Date:  2015-07-04       Impact factor: 9.623

Review 2.  Immunotoxicology: role in the safety assessment of drugs.

Authors:  Jacques Descotes
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

3.  High-throughput virtual screening of small-molecule inhibitors targeting immune cell checkpoints to discover new immunotherapeutics for human diseases.

Authors:  Satyendra Singh; Ketan Kumar; Mamta Panda; Aryan Srivastava; Amit Mishra; Vijay Kumar Prajapati
Journal:  Mol Divers       Date:  2022-05-28       Impact factor: 2.943

4.  Prevention of primary non-function of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agents.

Authors:  C Gysemans; K Stoffels; A Giulietti; L Overbergh; M Waer; M Lannoo; U Feige; C Mathieu
Journal:  Diabetologia       Date:  2003-07-17       Impact factor: 10.122

5.  Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells.

Authors:  Genc Basha; Tatiana I Novobrantseva; Nicole Rosin; Yuen Yi C Tam; Ismail M Hafez; Matthew K Wong; Tsukasa Sugo; Vera M Ruda; June Qin; Boris Klebanov; Marco Ciufolini; Akin Akinc; Ying K Tam; Michael J Hope; Pieter R Cullis
Journal:  Mol Ther       Date:  2011-10-04       Impact factor: 11.454

Review 6.  Recreational and occupational field exposure to freshwater cyanobacteria--a review of anecdotal and case reports, epidemiological studies and the challenges for epidemiologic assessment.

Authors:  Ian Stewart; Penelope M Webb; Philip J Schluter; Glen R Shaw
Journal:  Environ Health       Date:  2006-03-24       Impact factor: 5.984

Review 7.  Innate Immunity Modulating Impurities and the Immunotoxicity of Nanobiotechnology-Based Drug Products.

Authors:  Claire K Holley; Marina A Dobrovolskaia
Journal:  Molecules       Date:  2021-12-01       Impact factor: 4.411

8.  Diagnostic and therapeutic challenges of EBV-positive mucocutaneous ulcer: a case report and systematic review of the literature.

Authors:  Toni K Roberts; Xueyan Chen; Jay Justin Liao
Journal:  Exp Hematol Oncol       Date:  2016-04-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.